(Q36884097)

16 August 2017

1 reference

title

Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines (English)

1 reference

16 August 2017

1 reference

T Fukasawa

1

1 reference

16 August 2017

A Suzuki

series ordinal

2

1 reference

16 August 2017

K Otani

series ordinal

3

1 reference

16 August 2017

language of work or name

1 reference

1 August 2007

1 reference

Journal of Clinical Pharmacy and Therapeutics

16 August 2017

1 reference

16 August 2017

32

1 reference

16 August 2017

4

1 reference

16 August 2017

333-341

1 reference

Pharmacogenomics: translating functional genomics into rational therapeutics

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Biochemistry and molecular biology of the human CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Identification and functional characterization of eight CYP3A4 protein variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Expression of cytochrome P450 3A in amphibian, rat, and human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Genetic contribution to variable human CYP3A-mediated metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Pharmacokinetics of midazolam and 1'-hydroxymidazolam in Chinese with different CYP3A5 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Genetic variability in CYP3A5 and its possible consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Unusual side-effects due to clobazam: a case report with genetic study of CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Induction of the metabolism of etizolam by carbamazepine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

The role of cytochrome P450 2C19 activity in flunitrazepam metabolism in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Midazolam is metabolized by at least three different cytochrome P450 enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Single oral dose pharmacokinetics of quazepam is influenced by CYP2C19 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Effects of itraconazole on the plasma kinetics of quazepam and its two active metabolites after a single oral dose of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Drug interaction between St John's Wort and quazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

In vitro metabolism of quazepam in human liver and intestine and assessment of drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Effects of clobazam and its active metabolite on GABA-activated currents in rat cerebral neurons in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Several new benzodiazepines selectively interact with a benzodiazepine receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Relationships of brain and plasma levels of quazepam, flurazepam, and their metabolites with pharmacological activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00829.X

10.1111/J.1365-2710.2007.00829.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference